Basecamp Export

Exported Mar 17, 2025 at 3:01 PM

CSTE/APHL/CDC Serology and Immunity Workgroup

This workgroup is convened for bi-directional discussions between CDC/APHL/CSTE regarding increasing use of serology during the COVID-19 response. This group will discuss issues around the interpretation of serology results and the utility for understanding disease burden. This group will also discuss different sero-prevalence approaches, challenges, and developed protocols that may serve as resources for other jurisdictions implementing sero-prevalence studies.

Meredith Lichtenstein

CSTE

mlichtenstein@cste.org

Kelly Wroblewski

kelly.wroblewski@aphl.org

Sarah Park

State Epidemiologist at HI

sarah.park@doh.hawaii.gov

Mia Israel

Program Analyst at CSTE

misrael@cste.org

Mimi Huynh

Program Analyst at CSTE

mhuynh@cste.org

Hannah Gould

hgould@health.nyc.gov

Janet Hamilton

CSTE

jhamilton@cste.org

Jennifer Baumgartner

JBaumgar@health.nyc.gov

molly

mahowell@nd.gov

Monica Parker

monica.parker@health.ny.gov

Grace Kubin

grace.kubin@dshs.texas.gov

Katherine Lamba

katherine.lamba@cdph.ca.gov

Amy Schuh

Nottasorn

Megha Mehrotra

Senior Epidemiologist, CDPH

Megha.Mehrotra@cdph.ca.gov

Amelia Blumberg

CSTE

ablumberg@cste.org

Steven Alles

c-salles@pa.gov

Ian Plumb

idplumb@hotmail.com

Chas DeBolt WA DOH

chas.debolt@doh.wa.gov